What is the diagnosis and management of recurrent syncope (fainting spells)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Recurrent syncope is typically diagnosed and managed based on the underlying cause, with a focus on cardiac, orthostatic, and reflex-mediated causes. The diagnosis and management of recurrent syncope involve a thorough evaluation to identify the underlying cause, which can be cardiac, orthostatic, or reflex-mediated, such as vasovagal syncope (VVS) 1.

Diagnosis

  • The initial evaluation should include a thorough medical history, physical examination, and electrocardiogram (ECG) to identify potential cardiac causes of syncope 1.
  • Patients with suspected cardiac syncope may require further testing, such as echocardiography, stress testing, and electrophysiological studies 1.
  • Tilt testing and carotid massage may be used to diagnose neurally mediated syncope, including VVS 1.

Management

  • Hospital evaluation and treatment are recommended for patients with serious medical conditions potentially relevant to the cause of syncope 1.
  • Patients with presumptive reflex-mediated syncope, such as VVS, can be managed in the outpatient setting in the absence of serious medical conditions 1.
  • Treatment of VVS typically involves reassurance, education, and lifestyle modifications, such as avoiding volume depletion and prolonged exposure to upright posture and/or hot confining environments 1.
  • Medications such as midodrine and fludrocortisone may be effective in treating VVS, but the evidence is limited 1.
  • Pacemaker or implantable cardioverter-defibrillator (ICD) placement may be considered in patients with arrhythmic syncope or other cardiac causes of syncope 1.

Special Considerations

  • Patients with recurrent syncope despite conservative therapy may require more aggressive treatment, including medication or device therapy 1.
  • Patients with unexplained syncope and structural heart disease or abnormal ECG findings require further cardiac evaluation and may be at higher risk of arrhythmias and mortality 1.
  • Psychiatric assessment may be recommended in patients with frequent recurrent syncope and multiple other somatic complaints, as psychiatric illness may be a contributing factor 1.

From the Research

Diagnosis of Recurrent Syncope

  • The diagnosis of recurrent syncope can be made by clinical method associated with the electrocardiogram in up to 50% of patients 2
  • A detailed history can often yield an accurate diagnosis in most young patients, while older patients may require a more comprehensive diagnostic assessment 3
  • The initial assessment for all patients presenting with syncope includes a detailed history, physical examination, and electrocardiography 4

Management of Recurrent Syncope

  • The backbone of therapy is educating the patient, avoiding precipitating factors, maintaining hydration, and the application of physical counter-pressure maneuvers 3, 5
  • Conservative management with education, exercise, and physical maneuvers, and aggressive volume repletion is adequate for controlling symptoms in most patients 6
  • Pharmacologic interventions may be appropriate for some patients, but have limited evidence of efficacy in preventing syncope 5, 4
  • Drug therapy is rarely warranted, but may include fludrocortisone, alpha-agonists, and selective serotonin reuptake inhibitors 3
  • Permanent cardiac pacing is rarely needed and randomized trials do not support its use 3

Treatment Options

  • Non-pharmacological approaches, such as education and physical maneuvers, are often effective in managing recurrent syncope 6, 5
  • Pharmacological approaches, such as vasopressor agents, beta-blockers, and neurohormonal agents, may be necessary for some patients 6
  • Device-based therapy, such as pacemakers or radiofrequency ablation, may be considered for patients with refractory syncope 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Syncope: epidemiology, etiology, and prognosis.

Frontiers in physiology, 2014

Research

Management strategies for recurrent vasovagal syncope.

Internal medicine journal, 2010

Research

Syncope: Evaluation and Differential Diagnosis.

American family physician, 2017

Research

Syncope.

Continuum (Minneapolis, Minn.), 2017

Research

Non-invasive management of vasovagal syncope.

Autonomic neuroscience : basic & clinical, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.